Therapeutic Asset Ratings
7,021 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Eloxatin
Peripheral Neuropathy
Tanta University
P3
BBB
(72)
Eloxatin
Rectal Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris
P3
BBB
(72)
Epirubicin
Advanced/Metastatic Gastroesophageal Adenocarcinoma
Diwakar Davar
P3
BBB
(72)
Epirubicin
Lung Non-Small Cell Squamous Carcinoma
Shanghai Henlius Biotech
P3
BBB
(72)
Equine Atg
Acute Lymphoblastic Leukemia
Instituto Nacional de Cancer, Brazil
P3
BBB
(72)
ETOPOSIDE
Recurrent Childhood Acute Myeloid Leukemia
Joanna Yi
P3
BBB
(72)
FILGRASTIM
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer Center
P3
BBB
(72)
FILGRASTIM
Hematologic Diseases
Anaveon AG
P3
BBB
(72)
FILGRASTIM
Recurrent Grade 3 Follicular Lymphoma
Fred Hutchinson Cancer Center
P3
BBB
(72)
FLUOROURACILUM
Rectal Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BBB
(72)
FLUOROURACILUM
Rectal Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris
P3
BBB
(72)
Fruquintinib
Metastasis From Malignant Tumor Of Colon
Peking University
P3
BBB
(72)
Hycamtin
Non-Small Cell Lung Carcinoma
Fox Chase Cancer Center
P3
BBB
(72)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Inflammatory Breast Carcinoma
Hoffmann-La Roche
P3
BBB
(72)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
MALT Lymphoma
City of Hope Medical Center
P3
BBB
(72)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Refractory Diffuse Large B-Cell Lymphoma
Sun Yat-sen University
P3
BBB
(72)
Inno-206
B-Cell Adult Acute Lymphocytic Leukemia
Massachusetts General Hospital
P3
BBB
(72)
Inno-206
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BBB
(72)
Inno-206
Peritoneal Neoplasm
Eli Lilly and Company
P3
BBB
(72)
Inno-206
Recurrent Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
BBB
(72)
Inno-206
Breast Carcinoma
Tanta University
P3
BBB
(72)
Irinotecan
Fallopian Tube Mucinous Adenocarcinoma
M.D. Anderson Cancer Center
P3
BBB
(72)
Irinotecan
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Irinotecan
Fallopian Tube Transitional Cell Carcinoma
M.D. Anderson Cancer Center
P3
BBB
(72)
Irinotecan
Large Cell Lung Cancer
National Cancer Institute (NCI)
P3
BBB
(72)
Showing 226 to 250 of 7,021 assets
Previous
Page 10 of 281
Next